Key result
Premenopausal PCOS is linked to increased CIMT and a higher prevalence of subclinical atherosclerosis.
Why the study?
PCOS is associated with cardiometabolic risk, but its relationship with subclinical atherosclerosis in premenopausal women remains unclear.
Is polycystic ovary syndrome associated with increased markers of subclinical atherosclerosis in premenopausal women?
Systematic Review (n=9)
Is polycystic ovary syndrome associated with increased markers of subclinical atherosclerosis in premenopausal women?
PCOS in premenopausal women is associated with early vascular alterations and subclinical atherosclerosis, highlighting the potential need for cardiovascular risk assessment in this population.
Answers are grounded in this paper and cite their sources.
PCOS may warrant closer cardiometabolic monitoring in premenopausal women; leaves open causal inference and preventive strategies.
Background/Objectives: Polycystic ovary syndrome (PCOS) is increasingly recognized as a condition associated with cardiometabolic risk, yet its relationship with subclinical atherosclerosis in premenopausal women remains unclear. This systematic review aimed to synthesize and critically appraise the available evidence on the association between PCOS and markers of subclinical atherosclerosis. Methods: A systematic search of PubMed/MEDLINE, Embase, Scopus, Web of Science, and the Cochrane Library was conducted for studies published between January 2021 and January 2026. Eligible studies included premenopausal women with PCOS and assessed direct vascular markers or validated surrogate indicators of subclinical atherosclerosis. Data were synthesized narratively following PRISMA guidelines. Results: Nine studies were included, comprising five human clinical studies and four bioinformatics analyses. Evidence from imaging-based studies demonstrated increased carotid intima-media thickness, reduced wall shear stress, and a higher prevalence of subclinical vascular abnormalities in women with PCOS, particularly in some hyperandrogenic phenotypes. In contrast, adolescent populations showed predominantly metabolic and inflammatory alterations without clear structural vascular changes. Biochemical studies reported adverse lipid profiles and elevated atherogenic markers, while mechanistic studies highlighted inflammatory and mitochondrial pathways. Conclusions: Current evidence suggests that PCOS may be associated with early vascular alterations in premenopausal women; however, findings are limited by heterogeneity and observational designs. Further large-scale, phenotype-stratified prospective studies using standardized vascular assessments are needed to clarify cardiovascular risk in this population.
No takes yet. Share an insight, caveat, or question.
Elsheikh et al. (2026) conducted a systematic review in Polycystic ovary syndrome (PCOS) (n=9). Polycystic ovary syndrome (PCOS) was evaluated on Markers of subclinical atherosclerosis. Polycystic ovary syndrome in premenopausal women was associated with increased carotid intima-media thickness and a higher prevalence of subclinical vascular abnormalities.
Synapse has enriched 10 related papers. Consider them for comparative context: